. | Mortality (×103/year) . | Deaths per 100 000 (year−1) . | YLL (×106/year) . | LLE (years) . | Avoidable LLE (years) . | Avoidable mortality (×103/year) . | Mortality for disease categories (×103/year) . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LRI . | COPD . | LC . | CEV . | IHD . | Other NCD . | |||||||
Africa | 957 | 81 | 40.0 | 3.1 | 0.7 | 230 | 378 | 36 | 7 | 113 | 224 | 199 |
East Asia | 3112 | 196 | 67.4 | 3.9 | 3.0 | 2403 | 204 | 511 | 300 | 738 | 779 | 580 |
South Asia | 2809 | 119 | 83.6 | 3.3 | 1.9 | 1660 | 478 | 509 | 61 | 383 | 981 | 397 |
West Asia | 544 | 94 | 14.6 | 2.3 | 1.0 | 241 | 50 | 27 | 19 | 76 | 292 | 80 |
Europe | 790 | 133 | 14.3 | 2.2 | 1.7 | 608 | 54 | 49 | 54 | 64 | 313 | 256 |
Australia | 14 | 47 | 0.3 | 0.8 | 0.2 | 3 | 0.6 | 0.8 | 0.9 | 0.6 | 4 | 7 |
North America | 360 | 74 | 7.5 | 1.4 | 1.1 | 294 | 24 | 40 | 24 | 14 | 112 | 146 |
South America | 207 | 42 | 5.3 | 1.0 | 0.5 | 115 | 30 | 14 | 6 | 14 | 63 | 80 |
World | 8793 | 120 | 233 | 2.9 | 1.7 | 5554 | 1218 | 1187 | 472 | 1403 | 2768 | 1745 |
. | Mortality (×103/year) . | Deaths per 100 000 (year−1) . | YLL (×106/year) . | LLE (years) . | Avoidable LLE (years) . | Avoidable mortality (×103/year) . | Mortality for disease categories (×103/year) . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LRI . | COPD . | LC . | CEV . | IHD . | Other NCD . | |||||||
Africa | 957 | 81 | 40.0 | 3.1 | 0.7 | 230 | 378 | 36 | 7 | 113 | 224 | 199 |
East Asia | 3112 | 196 | 67.4 | 3.9 | 3.0 | 2403 | 204 | 511 | 300 | 738 | 779 | 580 |
South Asia | 2809 | 119 | 83.6 | 3.3 | 1.9 | 1660 | 478 | 509 | 61 | 383 | 981 | 397 |
West Asia | 544 | 94 | 14.6 | 2.3 | 1.0 | 241 | 50 | 27 | 19 | 76 | 292 | 80 |
Europe | 790 | 133 | 14.3 | 2.2 | 1.7 | 608 | 54 | 49 | 54 | 64 | 313 | 256 |
Australia | 14 | 47 | 0.3 | 0.8 | 0.2 | 3 | 0.6 | 0.8 | 0.9 | 0.6 | 4 | 7 |
North America | 360 | 74 | 7.5 | 1.4 | 1.1 | 294 | 24 | 40 | 24 | 14 | 112 | 146 |
South America | 207 | 42 | 5.3 | 1.0 | 0.5 | 115 | 30 | 14 | 6 | 14 | 63 | 80 |
World | 8793 | 120 | 233 | 2.9 | 1.7 | 5554 | 1218 | 1187 | 472 | 1403 | 2768 | 1745 |
Avoidable LLE and mortality were calculated by removing anthropogenic emissions in the model. Australia also includes other islands of Oceania. Data for all countries, including 95% uncertainty intervals, are given in the Supplementary material online, Tables (overall uncertainty about ±50%).
CEV, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; LC, lung cancer; LLE, loss of life expectancy; LRI, lower respiratory infections; NCD, non-communicable diseases; YLL, years of life lost.
Excess mortality expresses the number of deaths over a given period that would not occur in the absence of exposure.
. | Mortality (×103/year) . | Deaths per 100 000 (year−1) . | YLL (×106/year) . | LLE (years) . | Avoidable LLE (years) . | Avoidable mortality (×103/year) . | Mortality for disease categories (×103/year) . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LRI . | COPD . | LC . | CEV . | IHD . | Other NCD . | |||||||
Africa | 957 | 81 | 40.0 | 3.1 | 0.7 | 230 | 378 | 36 | 7 | 113 | 224 | 199 |
East Asia | 3112 | 196 | 67.4 | 3.9 | 3.0 | 2403 | 204 | 511 | 300 | 738 | 779 | 580 |
South Asia | 2809 | 119 | 83.6 | 3.3 | 1.9 | 1660 | 478 | 509 | 61 | 383 | 981 | 397 |
West Asia | 544 | 94 | 14.6 | 2.3 | 1.0 | 241 | 50 | 27 | 19 | 76 | 292 | 80 |
Europe | 790 | 133 | 14.3 | 2.2 | 1.7 | 608 | 54 | 49 | 54 | 64 | 313 | 256 |
Australia | 14 | 47 | 0.3 | 0.8 | 0.2 | 3 | 0.6 | 0.8 | 0.9 | 0.6 | 4 | 7 |
North America | 360 | 74 | 7.5 | 1.4 | 1.1 | 294 | 24 | 40 | 24 | 14 | 112 | 146 |
South America | 207 | 42 | 5.3 | 1.0 | 0.5 | 115 | 30 | 14 | 6 | 14 | 63 | 80 |
World | 8793 | 120 | 233 | 2.9 | 1.7 | 5554 | 1218 | 1187 | 472 | 1403 | 2768 | 1745 |
. | Mortality (×103/year) . | Deaths per 100 000 (year−1) . | YLL (×106/year) . | LLE (years) . | Avoidable LLE (years) . | Avoidable mortality (×103/year) . | Mortality for disease categories (×103/year) . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LRI . | COPD . | LC . | CEV . | IHD . | Other NCD . | |||||||
Africa | 957 | 81 | 40.0 | 3.1 | 0.7 | 230 | 378 | 36 | 7 | 113 | 224 | 199 |
East Asia | 3112 | 196 | 67.4 | 3.9 | 3.0 | 2403 | 204 | 511 | 300 | 738 | 779 | 580 |
South Asia | 2809 | 119 | 83.6 | 3.3 | 1.9 | 1660 | 478 | 509 | 61 | 383 | 981 | 397 |
West Asia | 544 | 94 | 14.6 | 2.3 | 1.0 | 241 | 50 | 27 | 19 | 76 | 292 | 80 |
Europe | 790 | 133 | 14.3 | 2.2 | 1.7 | 608 | 54 | 49 | 54 | 64 | 313 | 256 |
Australia | 14 | 47 | 0.3 | 0.8 | 0.2 | 3 | 0.6 | 0.8 | 0.9 | 0.6 | 4 | 7 |
North America | 360 | 74 | 7.5 | 1.4 | 1.1 | 294 | 24 | 40 | 24 | 14 | 112 | 146 |
South America | 207 | 42 | 5.3 | 1.0 | 0.5 | 115 | 30 | 14 | 6 | 14 | 63 | 80 |
World | 8793 | 120 | 233 | 2.9 | 1.7 | 5554 | 1218 | 1187 | 472 | 1403 | 2768 | 1745 |
Avoidable LLE and mortality were calculated by removing anthropogenic emissions in the model. Australia also includes other islands of Oceania. Data for all countries, including 95% uncertainty intervals, are given in the Supplementary material online, Tables (overall uncertainty about ±50%).
CEV, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; IHD, ischaemic heart disease; LC, lung cancer; LLE, loss of life expectancy; LRI, lower respiratory infections; NCD, non-communicable diseases; YLL, years of life lost.
Excess mortality expresses the number of deaths over a given period that would not occur in the absence of exposure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.